» Articles » PMID: 22911551

Novel Insight into the Role of GAPDH Playing in Tumor

Overview
Specialty Oncology
Date 2012 Aug 23
PMID 22911551
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The role of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) being consistently regarded as the main housekeeping gene and reference gene/protein for expression quantification in tumors has been gradually questioned and challenged by accumulated experiment evidence. The current review notified that the GAPDH expression was deregulated in lung cancer, renal cancer, breast cancer, gastric cancer, glioma, liver cancer, colorectal cancer, melanoma, prostatic cancer, pancreatic cancer and bladder cancer. Interestingly, GAPDH was commonly up-regulated in a variety of types of cancer, which was revealed to be potentially required for the cancer cell growth and tumor formation. The relevant mechanisms were also discussed in current review. This work might provide useful insights for future studies on GAPDH in tumors.

Citing Articles

Enhanced proteomic profiling of human plasma-derived extracellular vesicles through charge-based fractionation to advance biomarker discovery potential.

Su X, Junior G, Marie A, Gregus M, Figueroa-Navedo A, Ghiran I J Extracell Vesicles. 2024; 13(12):e70024.

PMID: 39641316 PMC: 11621968. DOI: 10.1002/jev2.70024.


The therapeutic effect of a novel GAPDH inhibitor in mouse model of breast cancer and efficacy monitoring by molecular imaging.

Zhang Y, Zhang W, Kong X, Hai W, Guo R, Zhang M Cancer Cell Int. 2024; 24(1):188.

PMID: 38811918 PMC: 11138053. DOI: 10.1186/s12935-024-03361-x.


Clinical efficacy and potential mechanism of ginseng polysaccharides in the treatment of non-small cell lung cancer based on meta-analysis associated with network pharmacology.

Zhao Q, Bai L, Zhu D, Li T, Xu J, Xu Y Heliyon. 2024; 10(6):e27152.

PMID: 38496882 PMC: 10944195. DOI: 10.1016/j.heliyon.2024.e27152.


In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.

Gambichler T, Harnischfeger F, Skrygan M, Majchrzak-Stiller B, Buchholz M, Muller T Int J Mol Sci. 2023; 24(20).

PMID: 37895015 PMC: 10607550. DOI: 10.3390/ijms242015336.


InterOpt: Improved gene expression quantification in qPCR experiments using weighted aggregation of reference genes.

Salimi A, Rahmani S, Sharifi-Zarchi A iScience. 2023; 26(10):107945.

PMID: 37829204 PMC: 10565776. DOI: 10.1016/j.isci.2023.107945.


References
1.
Ohl F, Jung M, Radonic A, Sachs M, Loening S, Jung K . Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer. J Urol. 2006; 175(5):1915-20. DOI: 10.1016/S0022-5347(05)00919-5. View

2.
Goidin D, Mamessier A, Staquet M, Schmitt D, Berthier-Vergnes O . Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal Biochem. 2001; 295(1):17-21. DOI: 10.1006/abio.2001.5171. View

3.
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z . 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006; 49(5):798-805. DOI: 10.1016/j.eururo.2005.11.035. View

4.
Cuezva J, Chen G, Alonso A, Isidoro A, Misek D, Hanash S . The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis. 2004; 25(7):1157-63. DOI: 10.1093/carcin/bgh113. View

5.
Rubporn A, Srisomsap C, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Svasti J . Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Cancer Genomics Proteomics. 2009; 6(4):229-37. View